IMMP1L

Across TCGA pan-cancer cohorts, IMMP1L mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated IMMP1L data layer compared with 24 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher IMMP1L mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated IMMP1L expression acts as an unfavorable survival marker.

UCEC, CCRCC, and GBM are the cancer types where IMMP1L mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.840	0.973	.010	16	view →
CCRCC	DFS	Median	II,III,IV	0.542	0.831	.004	10	view →
GBM	DFS	Median	All	0.479	0.823	.013	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

IMMP1L–UCEC (DFS)

Open the UCEC breakdown →